Skip to main content
Signal8

Fresenius SE & Co. KGaA (FSNUY)

Sector: Surgical & Medical Instruments & Apparatus

Industry: Medical - Care Facilities

Fresenius SE & Co. KGaA logo

Fresenius SE & Co. KGaA

OTC:FSNUYHealthcare
-2.72%$14.28
Mkt Cap$128.69B
EV-
Float1.64B
O/S9.01B
VOL131K sh
$ Vol$1.88M
RVOL1.37×
Inst Own-
SI<0.1%
Net Cash/Sh-
Div Yield2.13%
Dilution
Fresenius SE & Co. KGaA logoOTC:FSNUY$14.28-2.72%
Historical Data
DateOpenHighLowCloseVolume
Nov 19, 202614.5214.8114.2214.28131,380
Nov 18, 202614.7614.8514.6614.6883,359
Nov 17, 202614.7714.9114.7714.7865,444
Nov 16, 202614.9815.0114.7914.7977,867
Nov 13, 202614.8014.8514.7914.8050,077
Nov 12, 202614.9515.0114.7014.7278,476
Nov 11, 202614.7214.7614.6314.7269,609
Nov 10, 202614.9815.0314.8914.9967,900
Nov 9, 202614.7814.9514.7014.86111,243
Nov 6, 202614.3214.6414.3214.5280,570
Nov 5, 202614.4814.7914.4214.42292,391
Nov 4, 202614.3014.5714.2614.41147,960
Nov 3, 202613.6313.8613.5313.6190,403
Nov 2, 202613.6713.7113.4713.5687,463
Oct 30, 202613.3313.3713.3013.3583,260
Oct 29, 202613.0913.1712.9413.0479,553
Oct 28, 202612.9013.0112.8112.8660,091
Oct 27, 202612.9312.9612.8012.8166,789
Oct 26, 202613.0913.0912.8312.93100,146
Oct 23, 202612.8813.0312.6812.8898,691
Analyst Coverage
Analyst Coverage
ConsensusBuy
Price Target
Not available
Ratings Distribution
BUY
1
HOLD
0
SELL
0
TOTAL1
Insider Trades
No insider transactions for this companyForeign private issuers and non-reporting entities don't file Form 4/5.
Shareholders
--
Institutional
(8)
--
Insiderⓘ
(0)
--
5%+ Owners
(0)
--
Unattributed (incl. retail)ⓘ
Sources: 13F
Insiders & Institutional Holders
About

Fresenius SE & Co. KGaA operates as a diverse healthcare enterprise, supplying a comprehensive array of products and services primarily focused on dialysis, hospital management, and outpatient medical care.

Its activities are structured across four main divisions: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care division is dedicated to individuals living with chronic kidney failure, offering essential items like dialyzers, hemodialysis machines, and related disposable supplies, alongside various dialysis-specific services. Fresenius Kabi concentrates on the therapeutic treatment and care of ill patients.

Its extensive product range includes intravenous pharmaceuticals, such as generic drugs for oncology, anesthetics, pain relief, anti-infectives, and critical care.

Additionally, it provides parenteral and enteral nutritional products, infusion solutions, and blood volume expanders for infusion therapy. The segment also develops biosimilars—biological medicines for autoimmune and cancer conditions—and manufactures medical devices and disposables crucial for administering IV generics, infusion treatments, and clinical nutrition. Transfusion products for blood component collection and corporeal therapies are also part of its offerings. Fresenius Helios manages significant healthcare operations, encompassing 90 hospitals, approximately 130 outpatient clinics, and 6 prevention centers throughout Germany. In Spain, its presence includes 49 hospitals, 88 outpatient clinics, and around 300 risk prevention centers. This segment also delivers fertility treatment services through 33 clinics and an additional 39 sites located across 10 countries on three continents. Finally, the Fresenius Vamed division specializes in project management and service delivery for hospitals and other healthcare facilities.

Its offerings span project development, meticulous planning, and turnkey construction solutions. Furthermore, it provides ongoing maintenance, technical oversight, and operational management services.

The company, initially known as Fresenius SE, officially changed its name to Fresenius SE & Co. KGaA in January 2011. Founded in 1912, Fresenius SE & Co. KGaA maintains its corporate headquarters in Bad Homburg vor der Höhe, Germany.

Key Metrics
Market Cap$128.69B
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership--

based on 9.01B shares outstanding

SectorHealthcare
IndustryMedical - Care Facilities
ExchangeOTC
CountryDEDE
IPO Date-
Shares Outstanding9.01B
Authorized Shares
Float1.64B
52-Week Range
$11.67$33.93
$14.28(12th percentile)
Volume
Average Daily Volume95.59K
131.38K today vs 95.59K avg(+37%)

30d Avg

95.59K

60d Avg

236.67K

90d Avg

188.51K

Earnings
Dividend History
TTM Yield
2.13%
Paid annually
Annual (LTM)
$0.30
Latest
$0.3048
May 26, 26
5Y Growth
+2.69%
per year
Compliance Status
Loading compliance data...

Fresenius SE & Co. KGaA (OTC: FSNUY) traded at $14.28 on Nov 19, 2026, down 2.72% from the previous close of $14.68. 52-week range: $11.67 to $33.93. The company is in the Healthcare sector (Medical - Care Facilities).